What is the next earnings date for TTNP stock?
TITAN PHARMACEUTICALS INC (TTNP) will report earnings on 2026-01-01.
TITAN PHARMACEUTICALS INC (TTNP) Forecast, Price Target & Analyst Ratings
NASDAQ:TTNP • US8883147055
Current stock price
4.61 USD
-0.18 (-3.76%)
At close:
5.91 USD
+1.3 (+28.2%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TITAN PHARMACEUTICALS INC (TTNP).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jan 1, 2026
- Period
- Q1 / 2025
- EPS Estimate
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $4.61 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
TTNP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TTNP.
In the previous month the buy percentage consensus was at a similar level.
TTNP was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-05-26 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-02-18 | Maxim Group | Upgrade | Hold -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jan 1, 2026
- Period
- Q1 / 2025
- EPS Estimate
- N/A
- Revenue Estimate
- N/A
- Revenue Q2Q
- N/A
- EPS Q2Q
- N/A
- Number of Analysts
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
TTNP is expected to report earnings on 1/1/2026. The consensus EPS estimate for the next earnings is 0 USD and the consensus revenue estimate is null USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 1.526M -68.46% | 557K -63.50% | 184K -66.97% | N/A -100.00% | |
| EBITDA YoY % growth | -9.133M -29.38% | -10.039M -9.92% | -7.165M 28.63% | N/A 36.47% | |
| EBIT YoY % growth | -9.354M -27.25% | -10.235M -9.42% | -7.277M 28.90% | N/A 37.38% | |
| Operating Margin | -612.98% | -1,837.52% | -3,954.89% | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 25 | |
|---|---|
| EPS Q2Q % growth | N/A |
| Revenue Q2Q % growth | N/A |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
TITAN PHARMACEUTICALS INC / TTNP Forecast FAQ
Can you provide the consensus rating for TITAN PHARMACEUTICALS INC stock?
The consensus rating for TITAN PHARMACEUTICALS INC (TTNP) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.